Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.
The chronic inflammatory liver disease primary sclerosing cholangitis (PSC) is associated with portal inflammation and the development of neolymphoid tissue in the liver. More than 70% of patients with PSC have a history of inflammatory bowel disease and we have previously reported that mucosal addr...
Prif Awduron: | Grant, A, Goddard, S, Ahmed-Choudhury, J, Reynolds, G, Jackson, D, Briskin, M, Wu, L, Hübscher, S, Adams, D |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2002
|
Eitemau Tebyg
-
Characterization of CCL21 expression in human secondary lymphoid organs and ectopic lymphoid tissues
gan: Bugatti, S, et al.
Cyhoeddwyd: (2007) -
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis.
gan: Manzo, A, et al.
Cyhoeddwyd: (2007) -
Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells
gan: Strieter Robert, et al.
Cyhoeddwyd: (2003-11-01) -
CCL21 relationship with lymphoid neogenesis and lymphatic vascular system in chronically inflamed synovium
gan: Manzo, A, et al.
Cyhoeddwyd: (2005) -
Chemokines and Innate Lymphoid Cells in Skin Inflammation
gan: Zhengwang Sun, et al.
Cyhoeddwyd: (2021-11-01)